Progress and Obstacles in Understanding Pathological Mechanisms and Developing Intelligent Diagnostic Approaches for Diabetic Optic Neuropathy - Top-Institutions - MDSpire

Progress and Obstacles in Understanding Pathological Mechanisms and Developing Intelligent Diagnostic Approaches for Diabetic Optic Neuropathy

  • By

  • Bingying Liu

  • Jian Lian

  • Yuhan Liu

  • Wenwen Xu

  • Qiang Zhu

  • Wanzhen Jiao

  • March 1, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Neuro-ophthalmology
    • Diabetes-related eye disease
    • Medical AI

  • #2

    Massachusetts Eye and Ear Infirmary (Harvard Medical School)
    Massachusetts Eye and Ear Infirmary (Harvard Medical School)

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Neuro-ophthalmology
    • Diabetic eye disease
    • AI in ophthalmology

  • #3

    Moorfields Eye Hospital NHS Foundation Trust
    Moorfields Eye Hospital NHS Foundation Trust

    London, N/A

    Key Differentiators

    • Ophthalmology
    • Neuro-ophthalmology
    • Diabetic eye disease
    • Medical imaging AI

  • #4

    Bascom Palmer Eye Institute (University of Miami)
    Bascom Palmer Eye Institute (University of Miami)

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Neuro-ophthalmology
    • Diabetic eye disease

Original Source(s)

Progress and Obstacles in Understanding Pathological Mechanisms and Developing Intelligent Diagnostic Approaches for Diabetic Optic Neuropathy

  • by Bingying Liu, Jian Lian, Yuhan Liu, Wenwen Xu, Qiang Zhu, Wanzhen Jiao

  • March 1, 2026

Related Content

Experts question diet guidelines' higher protein-intake advice

Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy

Neo or Not Neo? Widefield OCT-A Reveals Hidden Neovascularization

Utilizing OCT and OCT-A technologies revealed critical insights into a patient’s complex retinopathy, as highlighted by Dr. Julie Rodman.